Know your enemy: understanding the pathophysiology of pulmonary hypertension.
作者信息
Shimoda Larissa A
机构信息
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L995-L997. doi: 10.1152/ajplung.00111.2020. Epub 2020 Apr 1.
Abstract
摘要
相似文献
1
Know your enemy: understanding the pathophysiology of pulmonary hypertension.了解你的敌人：认识肺动脉高压的病理生理学
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L995-L997. doi: 10.1152/ajplung.00111.2020. Epub 2020 Apr 1.
2
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.用正确的名称称呼它——肺动脉高压而非动脉性肺动脉高压：对一种广为人知的疾病的全球健康影响以及肺血管研究所的作用的认识不断提高。
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
3
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?多组学：通往理解肺动脉高压之路的下一步？
Thorax. 2019 Apr;74(4):317-318. doi: 10.1136/thoraxjnl-2018-212840. Epub 2019 Jan 24.
4
Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.肺血管阻力在肺动脉高压患者中的临床应用
J Cardiothorac Surg. 2021 Oct 20;16(1):311. doi: 10.1186/s13019-021-01696-4.
5
Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.剖析肺动脉高压中的大熔炉现象
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1329-1331. doi: 10.1164/rccm.202001-0156ED.
6
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.关卡激酶1促进肺动脉高压的发展。
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
7
A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.一种用于肺动脉高压免疫调节的新型肽。
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1460-1461. doi: 10.1164/rccm.201902-0388ED.
8
"Rehab for all!" Is it too early in pulmonary arterial hypertension?“全民康复！”对于肺动脉高压而言，现在提这个是否为时过早？
Eur Respir J. 2019 Nov 7;54(5). doi: 10.1183/13993003.01558-2019. Print 2019 Nov.
9
Real-World Data for Pulmonary Arterial Hypertension.肺动脉高压的真实世界数据。
Chest. 2019 Apr;155(4):653-654. doi: 10.1016/j.chest.2019.01.031.
10
Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.为肺动脉高压中肺血管阻力难题增添了重要一环。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.00962-2020. Print 2020 Jul.
引用本文的文献
1
World health days in May 2020: pulmonary hypertension; asthma; and tobacco-, smoking-, and vaping-related disease in focus.2020年5月的世界卫生日：聚焦肺动脉高压、哮喘以及与烟草、吸烟和电子烟相关的疾病。
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L988-L991. doi: 10.1152/ajplung.00115.2020. Epub 2020 Apr 1.
本文引用的文献
1
Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.缺氧促进肺血管重塑的细胞通路
Physiology (Bethesda). 2020 Jul 1;35(4):222-233. doi: 10.1152/physiol.00039.2019.
2
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.用正确的名称称呼它——肺动脉高压而非动脉性肺动脉高压：对一种广为人知的疾病的全球健康影响以及肺血管研究所的作用的认识不断提高。
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
3
Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.肺部血管中的线粒体在健康和疾病中的作用：氧感应、代谢和动力学。
Compr Physiol. 2020 Mar 12;10(2):713-765. doi: 10.1002/cphy.c190027.
4
Current and future treatments of pulmonary arterial hypertension.肺动脉高压的当前及未来治疗方法。
Br J Pharmacol. 2021 Jan;178(1):6-30. doi: 10.1111/bph.15016. Epub 2020 Mar 23.
5
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment.肺动脉平滑肌和内皮细胞在肺动脉高压及 TGF-β治疗中的稳定同位素代谢组学研究。
Sci Rep. 2020 Jan 15;10(1):413. doi: 10.1038/s41598-019-57200-5.
6
Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.肺动脉高压与右心衰竭中的性别、性别差异和性激素。
Compr Physiol. 2019 Dec 18;10(1):125-170. doi: 10.1002/cphy.c190011.
7
Pulmonary vasoconstriction in steers at high altitude.高原地区公牛的肺血管收缩
J Appl Physiol (1985). 1963 May 1;18(3):567-574. doi: 10.1152/jappl.1963.18.3.567.
8
Genetics and genomics of pulmonary arterial hypertension.肺动脉高压的遗传学和基因组学。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01899-2018. Print 2019 Jan.
9
Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.HIF-2α 抑制剂治疗肺动脉高压的血管重构和右心衰竭。
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1423-1434. doi: 10.1164/rccm.201710-2079OC.
10
ORAI Channels as Potential Therapeutic Targets in Pulmonary Hypertension.ORAI 通道作为肺动脉高压的潜在治疗靶点。
Physiology (Bethesda). 2018 Jul 1;33(4):261-268. doi: 10.1152/physiol.00016.2018.
Zotero 插件